Tuesday, April 2, 2019

Strides Pharma Science gets EIR from USFDA for Singapore facility

Strides Pharma Science gets EIR from USFDA for Singapore facility The company had earlier in March announced receiving approval from the United States Food and Drug Administration for the greenfield oral dosage facility in Singapore.

from Moneycontrol Business News https://ift.tt/2FINi3D

No comments:

Post a Comment

Paras Defence shares soar 10% as Q2 net profit jumps 50% to Rs 14 crore

Paras Defence and Space Technologies shares surged following strong September quarter results, with net profit jumping 50% and revenue climb...